Dry eye device trial aims to unlock secrets in your tears
NCT ID NCT07175909
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests a device called Rexon-Eye that uses low-level electrical current to treat dry eye disease. Researchers will also analyze tear proteins to see how they change with treatment. The trial involves 75 adults with dry eye and aims to understand both the device's effectiveness and the biological markers of the condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Rexon-Eye electrotherapy device
- What this could lead to
- If successful, this could point toward a better way to diagnose and manage dry eye disease using tear protein analysis.
- What could go wrong
- This is a small, early-stage study with only 75 participants, so results may not apply to everyone. The device's long-term benefits and safety are still being evaluated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Hong Kong Polytechnic University, Hong Kong,
RECRUITINGHong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can insulin eye drops quench dry eyes?
- Can acne drug harm the eyes? new study investigates
- Which eye drop wins the dry eye battle? a Head-to-Head test
- Can a new eye drop soothe severe dry eye?
- Can a new eye drop soothe dry eye? a trial puts TRYPTYR to the test
- New imaging tools put to the test for measuring dry eye treatment effects